Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Joris Weiland"'
Autor:
Robin Arcani, Florian Correard, Pierre Suchon, Gilles Kaplanski, Rodolphe Jean, Raphael Cauchois, Marine Leprince, Vincent Arcani, Julie Seguier, Benjamin De Sainte Marie, Baptiste Andre, Marie Koubi, Pascal Rossi, Stéphane Gayet, Nirvina Gobin, Victoria Garrido, Joris Weiland, Elisabeth Jouve, Anne-Laure Couderc, Patrick Villani, Aurélie Daumas
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundTocilizumab and anakinra are anti-interleukin drugs to treat severe coronavirus disease 2019 (COVID-19) refractory to corticosteroids. However, no studies compared the efficacy of tocilizumab versus anakinra to guide the choice of the thera
Externí odkaz:
https://doaj.org/article/4fc10343fb484f138e16cd6442659fb8
Autor:
Charlotte Berard, Anne-Laure Couderc, Anais Courcier, Aurélie Daumas, Robin Arcani, Joris Weiland, Julie Berbis, Charlène Miola, Florian Correard, Patrick Villani
Publikováno v:
Drugs & Aging
Patients hospitalised with severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2; coronavirus 2019 disease (COVID-19)] infection are frequently older with co-morbidities and receiving polypharmacy, all of which are known risk factors for drug-d
Autor:
Aurélie Daumas, Emilie Nouguerède, Robin Arcani, Pierre Caunes, Joris Weiland, Zeinab Hamidou, Patrick Gil, Anne-Laure Couderc, Priscilla Clot-Faybesse, Patrick Villani, Charlotte Berard, Florian Correard, Charlène Miola, Anais Courcier, Julie Berbis
Publikováno v:
Journal of the American Medical Directors Association
Journal of the American Medical Directors Association, Elsevier, 2021, 22 (8), pp.1581-1587.e3. ⟨10.1016/j.jamda.2021.06.023⟩
Journal of the American Medical Directors Association, 2021, 22 (8), pp.1581-1587.e3. ⟨10.1016/j.jamda.2021.06.023⟩
Journal of the American Medical Directors Association, Elsevier, 2021, 22 (8), pp.1581-1587.e3. ⟨10.1016/j.jamda.2021.06.023⟩
Journal of the American Medical Directors Association, 2021, 22 (8), pp.1581-1587.e3. ⟨10.1016/j.jamda.2021.06.023⟩
Objectives To describe the clinical characteristics and management of residents in French nursing homes with suspected or confirmed coronavirus disease 2019 (COVID-19) and to determine the risk factors for COVID-19–related hospitalization and death